CLS Stock Overview
Operates as a health, wellness, and beauty retailer in South Africa and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CLS from our risk checks.
Clicks Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R338.86 |
52 Week High | R352.99 |
52 Week Low | R235.56 |
Beta | 0.17 |
11 Month Change | 1.75% |
3 Month Change | 18.65% |
1 Year Change | 19.70% |
33 Year Change | 27.83% |
5 Year Change | 65.30% |
Change since IPO | 8,701.56% |
Recent News & Updates
Recent updates
Shareholder Returns
CLS | ZA Consumer Retailing | ZA Market | |
---|---|---|---|
7D | 1.1% | 2.3% | 1.3% |
1Y | 19.7% | 15.5% | 2.9% |
Return vs Industry: CLS exceeded the ZA Consumer Retailing industry which returned 15.5% over the past year.
Return vs Market: CLS exceeded the ZA Market which returned 2.9% over the past year.
Price Volatility
CLS volatility | |
---|---|
CLS Average Weekly Movement | 4.0% |
Consumer Retailing Industry Average Movement | 4.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in ZA Market | 10.9% |
10% least volatile stocks in ZA Market | 3.3% |
Stable Share Price: CLS has not had significant price volatility in the past 3 months.
Volatility Over Time: CLS's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1968 | 18,741 | Bertina Engelbrecht | www.clicksgroup.co.za |
Clicks Group Limited, together with its subsidiaries, operates as a health, wellness, and beauty retailer in South Africa and internationally. It operates through two segments: Retail and Distribution. The company retails pharmacy, health, and beauty through stores, and in-store pharmacies for the middle to upper income markets under the Clicks brand name.
Clicks Group Limited Fundamentals Summary
CLS fundamental statistics | |
---|---|
Market cap | R80.67b |
Earnings (TTM) | R2.66b |
Revenue (TTM) | R43.42b |
30.4x
P/E Ratio1.9x
P/S RatioIs CLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLS income statement (TTM) | |
---|---|
Revenue | R43.42b |
Cost of Revenue | R33.43b |
Gross Profit | R9.99b |
Other Expenses | R7.33b |
Earnings | R2.66b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 11.16 |
Gross Margin | 23.00% |
Net Profit Margin | 6.12% |
Debt/Equity Ratio | 0% |
How did CLS perform over the long term?
See historical performance and comparison